The OECD identified antibiotic resistance as “one of the biggest threats to modern medicine,” adding that superbugs could kill 2.4 million people in Europe, North America and Australia over the next three decades. The report also found health complications linked to antibiotic resistance could cost $3.5 billion a year across 33 countries.
“A short-term investment to stem the superbug tide would save lives and money in the long run,” OECD said in the report.
OECD proposed a five-pronged approach to addressing antibiotic resistance that outlines the following initiatives:
- Promoting better hygiene
- Ending the over-prescription of antibiotics
- Quickly testing patients to ensure they receive the right antibiotic for infections
- Delaying antibiotic prescriptions
- Initiating mass media campaigns
To download the full report, click here.
More articles on clinical leadership and infection control:
Most cystic fibrosis patients receive insufficient antibiotic doses, study finds
Texas researchers to study whether malaria infection protects against Ebola
Machine learning model helps inform sepsis treatment in ER
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
